Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Vivanza Biosciences: Board Meeting Outcome for Outcome Of Board Meeting To Consider And Approve Unaudited Financial Results (Standalone And Consolidated) For Quarter Ended 30Th June 2026
News Announcement

Vivanza Biosciences: Board Meeting Outcome for Outcome Of Board Meeting To Consider And Approve Unaudited Financial Results (Standalone And Consolidated) For Quarter Ended 30Th June 2026

07-Aug-2026 Follow Value Research Online on Google download pdfDownload PDF Vivanza Bioscience

Approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended on 30th June 2026 along with year-to-date figures for the period from 1st April 2026 to 30th June 2026 together with the Limited Review Report (Annexure -A). and Other Business of the Company as enclosed.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan